2016
DOI: 10.1371/journal.pone.0155490
|View full text |Cite
|
Sign up to set email alerts
|

Activation of RhoA, but Not Rac1, Mediates Early Stages of S1P-Induced Endothelial Barrier Enhancement

Abstract: Compromised endothelial barrier function is a hallmark of inflammation. Rho family GTPases are critical in regulating endothelial barrier function, yet their precise roles, particularly in sphingosine-1-phosphate (S1P)-induced endothelial barrier enhancement, remain elusive. Confluent cultures of human umbilical vein endothelial cells (HUVEC) or human dermal microvascular endothelial cells (HDMEC) were used to model the endothelial barrier. Barrier function was assessed by determining the transendothelial elec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
29
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 30 publications
(30 citation statements)
references
References 54 publications
(100 reference statements)
1
29
0
Order By: Relevance
“…Y16 is a specific RhoA inhibitor developed in our laboratory, which fits into a surface groove of the DH‐PH domain of leukemia‐associated Rho GEF (LARG), a G‐protein‐regulated Rho GEF involved in RhoA activation . Y16 has been used for RhoA functional studies of a wide range, from endothelial barrier and macrophage phenotypes to contraction of intrapulmonary artery and airway smooth muscle . The main purpose for using Y16 in this study is to complement genetic deletion of RhoA to demonstrate the role of RhoA in Th17‐cell differentiation in vitro and Th17‐involved allergic airway inflammation in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…Y16 is a specific RhoA inhibitor developed in our laboratory, which fits into a surface groove of the DH‐PH domain of leukemia‐associated Rho GEF (LARG), a G‐protein‐regulated Rho GEF involved in RhoA activation . Y16 has been used for RhoA functional studies of a wide range, from endothelial barrier and macrophage phenotypes to contraction of intrapulmonary artery and airway smooth muscle . The main purpose for using Y16 in this study is to complement genetic deletion of RhoA to demonstrate the role of RhoA in Th17‐cell differentiation in vitro and Th17‐involved allergic airway inflammation in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…Fluorescence resonance energy transfer (FRET) analysis revealed spontaneous RhoA activity at intact intercellular junctions and in parallel to intercellular gap closure . RhoA via ROCK2b was found to prevent vascular leakage during leucocyte diapedesis and S1P was proposed to enhance barrier function at least in part via RhoA and ROCK . On the other hand, endothelial cells deficient in podocalyxin have delayed barrier recovery and sustained RhoA activation indicating a negative effect of RhoA .…”
Section: Maintenance and Stabilization Of The Endothelial Barrier In mentioning
confidence: 99%
“…These include myosin light chain (MLC) kinase (MLCK) and RhoA/ROCK signaling, which control myosin activity (Moy et al , 1993; Sheldon et al , 1993; Garcia et al , 1995; Verin et al , 1995; Yuan et al , 1997; Garcia et al , 1999; Tinsley et al , 2000; Yuan et al , 2002; Huang et al , 2003; Birukova et al , 2004; Breslin & Yuan, 2004; Tinsley et al , 2004b; Breslin et al , 2006; Reynoso et al , 2007; Kumar et al , 2009; Dudek et al , 2010; Beard et al , 2014). The balance of activities among members of the Rho family of small GTPases such as RhoA, Rac1, and Cdc42 have also been shown to be of importance for both disruption and stabilization of the endothelial barrier (Waschke et al , 2004a; Waschke et al , 2004b; Waschke et al , 2006; Baumer et al , 2008a; Schlegel et al , 2009; Schlegel & Waschke, 2009; Spindler et al , 2010; Breslin et al , 2015; Breslin et al , 2016; Zhang et al , 2016). In addition, there is increasing evidence that in addition to phosphorylation, other posttranslational modifications such as S-nitrosation of junctional proteins (Marin et al , 2012; Sánchez et al , 2013; Guequén et al , 2016), or specific palmitoylation of PKCβ by palmitoyl acyltransferase DHHC21 (Beard et al , 2016) can lead to elevated microvascular leakage.…”
Section: Determinants Of Endothelial Barrier Functionmentioning
confidence: 99%
“…Endothelial cytoskeleton and actin fiber dynamics are of significant importance in regulating endothelial permeability (Adderley et al , 2015a; Zhang et al , 2016) and they have been studied in the context of brain injury. One study showed that actin filaments are important to maintain the BBB, as treatment with cytochalasin-B, which disrupts actin integrity, caused BBB hyperpermeability (Nag, 1995).…”
Section: Microvascular Hyperpermeability In Injury or Disease Conditionsmentioning
confidence: 99%
See 1 more Smart Citation